Birdwatch Note Rating
2023-03-17 20:00:14 UTC - SOMEWHAT_HELPFUL
Rated by Participant: 3DB9A9BFA8F7A17A52D354D21DF008C4029727F3E8F4E6B7CD1449831C73A204
Participant Details
Original Note:
The puberty blocker Lupron was never approved for gender-affirming care: it was trialled and approved by the FDA for precocious puberty in 6-8 year old girls. There are currently no peer-reviewed long-term studies on the effects of blockers on sexual function and fertility. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/020263s050lbl.pdf
All Note Details